Cargando…
HER2 expression in breast cancer primary tumours and corresponding metastases. Original data and literature review
The aim of this study was to evaluate whether the HER2 expression in breast cancer is retained in metastases. The HER2 expression in primary tumours and the corresponding lymph node metastases were evaluated in parallel samples from 47 patients. The HercepTest was used for immunohistochemical analys...
Autores principales: | Carlsson, J, Nordgren, H, Sjöström, J, Wester, K, Villman, K, Bengtsson, N O, Ostenstad, B, Lundqvist, H, Blomqvist, C |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2004
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409528/ https://www.ncbi.nlm.nih.gov/pubmed/15150568 http://dx.doi.org/10.1038/sj.bjc.6601881 |
Ejemplares similares
-
Tumour microvessel density as predictor of chemotherapy response in breast cancer patients
por: Tynninen, O, et al.
Publicado: (2002) -
Cytotoxic T-cell precursor frequencies to HER-2 (369 – 377) in patients with HER-2/neu-positive epithelial tumours
por: Sotiropoulou, P A, et al.
Publicado: (2003) -
Marker genes for circulating tumour cells predict survival in metastasized breast cancer patients
por: Weigelt, B, et al.
Publicado: (2003) -
On the biological relevance of MHC class II and B7 expression by tumour cells in melanoma metastases
por: Bernsen, M R, et al.
Publicado: (2003) -
Wnt-signalling pathway in ovarian epithelial tumours: increased expression of β-catenin and GSK3β
por: Rask, K, et al.
Publicado: (2003)